MediciNova, Inc. (MNOV)
NASDAQ: MNOV · IEX Real-Time Price · USD
1.355
+0.025 (1.88%)
Apr 24, 2024, 4:30 PM EDT - Market closed

MediciNova Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2002
Revenue
104.040000000
Upgrade
Gross Profit
104.040000000
Upgrade
Selling, General & Admin
5.245.485.726.697.959.968.87.365.815.96
Upgrade
Research & Development
5.669.148.547.486.085.634.223.523.023.26
Upgrade
Other Operating Expenses
000000000.050.01
Upgrade
Operating Expenses
10.914.6314.2514.1814.0315.5913.0310.888.889.24
Upgrade
Operating Income
-9.9-14.63-10.22-14.18-14.03-15.59-13.03-10.88-8.88-9.24
Upgrade
Interest Expense / Income
0000000000
Upgrade
Other Expense / Income
-1.33-0.56-0.08-0.32-1.1-0.92-0.12-0.02-0.04-0.04
Upgrade
Pretax Income
-8.57-14.07-10.13-13.86-12.93-14.67-12.91-10.86-8.84-9.2
Upgrade
Income Tax
000-00.010.01-1.7400.01-0
Upgrade
Net Income
-8.57-14.07-10.13-13.85-12.94-14.68-11.16-10.87-8.85-9.2
Upgrade
Shares Outstanding (Basic)
49494944434135332724
Upgrade
Shares Outstanding (Diluted)
49494944434135332724
Upgrade
Shares Change
0.00%0.92%9.42%2.91%4.95%17.04%6.52%24.11%10.43%16.28%
Upgrade
EPS (Basic)
-0.17-0.29-0.21-0.31-0.30-0.36-0.32-0.33-0.33-0.38
Upgrade
EPS (Diluted)
-0.17-0.29-0.21-0.31-0.30-0.36-0.32-0.33-0.33-0.38
Upgrade
Free Cash Flow
-7.45-12.92-9.41-10.86-9.14-9.12-6.92-6.63-7.150.81
Upgrade
Free Cash Flow Per Share
-0.15-0.26-0.19-0.24-0.21-0.22-0.20-0.20-0.270.03
Upgrade
Gross Margin
100.00%-100.00%-------
Upgrade
Operating Margin
-990.03%--253.02%-------
Upgrade
Profit Margin
-857.15%--251.00%-------
Upgrade
Free Cash Flow Margin
-745.23%--233.07%-------
Upgrade
EBITDA
-8.35-13.85-9.89-13.62-12.91-14.64-12.88-10.85-8.81-9.16
Upgrade
EBITDA Margin
-835.37%--244.93%-------
Upgrade
Depreciation & Amortization
0.210.210.240.230.020.030.030.010.030.04
Upgrade
EBIT
-8.57-14.07-10.13-13.86-12.93-14.67-12.91-10.86-8.84-9.2
Upgrade
EBIT Margin
-856.85%--250.94%-------
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).